Advances in genetics: widening our understanding of prostate cancer

Por Pine, Angela C., Fioretti, Flavia F., Brooke, Greg N., Bevan, Charlotte L.
Publicado no F1000Res (2016)

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells

Por Ottaviani, Silvia, Brooke, Greg N, O'Hanlon-Brown, Ciara, Waxman, Jonathan, Ali, Simak, Buluwela, Laki
Publicado em 2013

Engineered repressors are potent inhibitors of androgen receptor activity

Por Brooke, Greg N., Powell, Sue M., Lavery, Derek N., Waxman, Jonathan, Buluwela, Laki, Ali, Simak, Bevan, Charlotte L.
Publicado em 2014

Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces

Por Grosdidier, Solène, Carbó, Laia R., Buzón, Víctor, Brooke, Greg, Nguyen, Phuong, Baxter, John D., Bevan, Charlotte, Webb, Paul, Estébanez-Perpiñá, Eva, Fernández-Recio, Juan
Publicado no Mol Endocrinol (2012)

Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer

Por Reebye, Vikash, Querol Cano, Laia, Lavery, Derek N., Brooke, Greg N., Powell, Sue M., Chotai, Deepa, Walker, Marjorie M., Whitaker, Hayley C., Wait, Robin, Hurst, Helen C., Bevan, Charlotte L.
Publicado no Mol Endocrinol (2012)

Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells

Por Brooke, Greg N., Gamble, Simon C., Hough, Michael A., Begum, Shajna, Dart, D. Alwyn, Odontiadis, Michael, Powell, Sue M., Fioretti, Flavia M., Bryan, Rosie A., Waxman, Jonathan, Wait, Robin, Bevan, Charlotte L.
Publicado no Mol Cell Proteomics (2015)

The co‐chaperone p23 promotes prostate cancer motility and metastasis

Por Querol Cano, Laia, Lavery, Derek N., Sin, Soraya, Spanjaard, Emma, Brooke, Greg N., Tilman, Jessica D., Abroaf, Ahmed, Gaughan, Luke, Robson, Craig N., Heer, Rakesh, Mauri, Francesco, de Rooij, Johan, Driouch, Keltouma, Bevan, Charlotte L.
Publicado no Mol Oncol (2014)